Moderna Inc (M1RN34)

Currency in BRL
21.18
+0.07(+0.33%)
Closed·
Unusual trading volume
Trading near 52-week High
M1RN34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.9222.00
52 wk Range
6.0222.00
Key Statistics
Bid/Ask
21.09 / 21.14
Prev. Close
21.11
Open
21.08
Day's Range
19.92-22
52 wk Range
6.02-22
Volume
101.92K
Average Volume (3m)
34.99K
1-Year Change
157.6642%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
M1RN34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Moderna Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 01, 2026
EPS / Forecast
-3.40 / --
Revenue / Forecast
389M / --
EPS Revisions
Last 90 days

M1RN34 Income Statement

Compare M1RN34 to Peers and Sector

Metrics to compare
M1RN34
Peers
Sector
Relationship
P/E Ratio
−9.9x−5.7x−0.4x
PEG Ratio
−1.550.030.00
Price/Book
4.3x2.9x2.6x
Price / LTM Sales
14.2x6.7x3.0x
Upside (Analyst Target)
-77.3%49.1%
Fair Value Upside
Unlock7.2%6.3%Unlock

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Employees
4700
Market
Brazil

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
190.36M47.98%4.02B
Other Institutional Investors
127.81M32.21%2.70B
Public Companies & Retail Investors
78.61M19.81%1.66B
Total
396.79M100.00%8.38B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC11.50%45,623,807963,119
BlackRock, Inc.7.47%29,635,876625,613

People Also Watch

116.66
CSCO34
-1.54%
116.24
AURA33
+1.52%
30.48
B1NT34
-1.93%
82.63
MSFT34
-2.28%
21.03
NVDC34
-0.43%

FAQ

What Is the Moderna (M1RN34) Stock Price Today?

The Moderna stock price today is 21.18 BRL.

What Stock Exchange Does Moderna Trade On?

Moderna is listed and trades on the B3 Stock Exchange.

What Is the Stock Symbol for Moderna?

The stock symbol for Moderna is "M1RN34."

What Is the Moderna Market Cap?

As of today, Moderna market cap is 167.85B BRL.

What Is Moderna's Earnings Per Share (TTM)?

The Moderna EPS (TTM) is -8.16.

From a Technical Analysis Perspective, Is M1RN34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Moderna Stock Split?

Moderna has split 1 times.

How Many Employees Does Moderna Have?

Moderna has 4700 employees.

What is the current trading status of Moderna (M1RN34)?

As of Jul 06, 2026, Moderna (M1RN34) is trading at a price of 21.18 BRL, with a previous close of 21.11 BRL. The stock has fluctuated within a day range of 19.92 BRL to 22.00 BRL, while its 52-week range spans from 6.02 BRL to 22.00 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.